Anthony Gentile
Corporate Officer/Principal bei BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Profil
Anthony Gentile ist Direktor des Programms für klinische Operationen und Finanzen bei Biohaven Pharmaceutical Holding Co. Ltd.
Aktive Positionen von Anthony Gentile
| Unternehmen | Position | Beginn |
|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | 01.02.2014 |
Ausbildung von Anthony Gentile
| Eastern Connecticut State University | Undergraduate Degree |
| University of Hartford | Graduate Degree |
| Rensselaer Polytechnic Institute | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
